Viewing Study NCT04996160

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:12 AM
Ignite Modification Date: 2026-01-24 @ 7:31 AM
Study NCT ID: NCT04996160
Status: RECRUITING
Last Update Posted: 2025-01-24
First Post: 2021-07-22
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Palbociclib in Combination With Chemotherapy in Pediatric Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (RELPALL2)
Sponsor: Tanja Andrea Gruber
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Lymphoblastic Leukemia, Pediatric View
None Relapsed Acute Lymphoblastic Leukemia View
None Refractory Acute Lymphoblastic Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ALL View
None Relapsed ALL View